Cover Image

Primary hyperoxaluria type 1 with HNF1β nephropathy: one case report

Saved in:

Bibliographic Details
Main Authors:	Xue-ran Li (Author), Nan-nan Du (Author), Wei Gao (Author), Dan Wang (Author), Qing-zhen Gao (Author)
Format:	Book
Published:	Editorial Department of Journal of Clinical Nephrology, 2024-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Type 1 primary hyperoxaluria in a male infant
by: Benjamin Waddell, et al.
Published: (2017)

Extreme intrafamilial variability of Saudi brothers with primary hyperoxaluria type 1
by: Alfadhel M, et al.
Published: (2012)

Lumasiran for primary hyperoxaluria type 1: What we have learned?
by: Xuan Gang, et al.
Published: (2023)

Primary Hyperoxaluria Type 1: The First Patient Treated with Lumasiran in Portugal
by: Madalena Almeida Borges, et al.
Published: (2023)

Bone health in children with primary hyperoxaluria type 1 following liver and kidney transplantation
by: Rainer Büscher, et al.
Published: (2024)

Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1
by: Benedetta Chiodini, et al.
Published: (2022)

Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1
by: Hossam Murad, et al.
Published: (2021)

A Single Nucleotide Variant in HNF-1β is associated with Maturity-Onset Diabetes of the Young in a Large Chinese Family
by: Peng ZHOU, et al.
Published: (2016)

Primary Hyperoxaluria in Korean Pediatric Patients
by: Yunsoo Choe, et al.
Published: (2019)

The Struggling Odyssey of Infantile Primary Hyperoxaluria
by: Adrien Guillaume, et al.
Published: (2021)

Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population
by: Wenying Wang, et al.
Published: (2019)

Case Report: effect of lumasiran treatment in a late preterm baby with antenatal diagnosis of primary hyperoxaluria type 1
by: Francesca Taroni, et al.
Published: (2024)

Antagonistic epistasis of Hnf4α and FoxO1 metabolic networks through enhancer interactions in β-cell function
by: Taiyi Kuo, et al.
Published: (2021)

Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma
by: Michelle X. Yang, et al.
Published: (2018)

Long-term outcome after combined or sequential liver and kidney transplantation in children with infantile and juvenile primary hyperoxaluria type 1
by: Sebastian Loos, et al.
Published: (2023)

Variants influencing age at diagnosis of HNF1A-MODY
by: Agnieszka H. Ludwig-Słomczyńska, et al.
Published: (2022)

Unusual cause of renal failure in infancy: Primary hyperoxaluria
by: Kanchan Channawar, et al.
Published: (2015)

Primary hyperoxaluria as a cause of renal failure in an infant
by: Hossein Emad Momtaz, et al.
Published: (2018)

MODY5 Hepatocyte Nuclear Factor 1ß (HNF1ß)-Associated Nephropathy: experience from a regional monogenic diabetes referral centre in Singapore
by: Clara Si Hua Tan MSc, et al.
Published: (2022)

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial
by: Yaacov Frishberg, et al.
Published: (2024)

Review of neurodevelopmental disorders in patients with HNF1B gene variations
by: Clara Marie Nittel, et al.
Published: (2023)

Protective roles of adiponectin and molecular signatures of HNF4α and PPARα as downstream targets of adiponectin in pancreatic β cells
by: Toshiharu Onodera, et al.
Published: (2023)

Mutation Analysis of the AGXT Gene in Combined Liver-Kidney and Isolated Liver Transplanted Children for Primary Hyperoxaluria Type 1: a Single Center Experience
by: Mehmet Turkmen, et al.
Published: (2022)

TGFβ Impairs HNF1α Functional Activity in Epithelial-to-Mesenchymal Transition Interfering With the Recruitment of CBP/p300 Acetyltransferases
by: Francesca Bisceglia, et al.
Published: (2019)

Left ventricular hypertrabeculation/noncompaction in hyperoxaluria
by: Josef Finsterer, et al.
Published: (2015)

Not only Alagille syndrome. Syndromic paucity of interlobular bile ducts secondary to HNF1β deficiency: a case report and literature review
by: Michele Pinon, et al.
Published: (2019)

Multiple myeloma initially presenting with oral mucosal neoplasm and concurrent cast nephropathy: one case report with a literature view
by: Zi-qing Gao, et al.
Published: (2024)

Severe child form of primary hyperoxaluria type 2 - a case report revealing consequence of GRHPR deficiency on metabolism
by: Jana Konkoľová, et al.
Published: (2017)

Mutation characteristics of primary hyperoxaluria in the Chinese population and current international diagnosis and treatment status
by: Xingying Zhu, et al.
Published: (2024)

Cardiac involvement of primary hyperoxaluria accompanied by non-compaction cardiomyopathy and patent ductus arteriosus
by: Nurcan Arat, et al.
Published: (2015)

p-hydroxy benzaldehyde attenuates intestinal epithelial barrier dysfunction caused by colitis via activating the HNF-1β/SLC26A3 pathway
by: Meng Liu, et al.
Published: (2024)

Cumulative evidence for relationships between multiple variants of HNF1B and the risk of prostate and endometrial cancers
by: Yu Tong, et al.
Published: (2018)

Two Novel AGXT Mutations Cause the Infantile Form of Primary Hyperoxaluria Type I in a Chinese Family: Research on Missed Mutation
by: Xiulan Lu, et al.
Published: (2019)

Relationship between transforming growth factor-β1 and type 2 diabetic nephropathy risk in Chinese population
by: Tianbiao Zhou, et al.
Published: (2018)

Efficiency of using Canephron® N in the treatment of children with secondary hyperoxaluria
by: T.P. Borysova
Published: (2017)

Hyperoxaluria; a risk factor or a consequence of recurrent pyelonephritis?
by: Natalia Stepanova
Published: (2021)

<it>HNF1A </it>G319S variant, active cigarette smoking and incident type 2 diabetes in Aboriginal Canadians: a population-based epidemiological study
by: Gittelsohn Joel, et al.
Published: (2011)

A rare case of hyperoxaluria presenting with acute liver injury and stone-free kidney injury
by: Si-eun Kim, et al.
Published: (2015)

Resequencing of genes for transforming growth factor β1 (<it>TGFB1</it>) type 1 and 2 receptors (<it>TGFBR1</it>, <it>TGFBR2</it>), and association analysis of variants with diabetic nephropathy
by: Patterson Chris C, et al.
Published: (2007)

Multiple hepatocyte nuclear factor 1A (HNF1A)-inactivated hepatocellular adenomas arising in a background of congenital hepatic fibrosis
by: Yangkyu Lee, et al.
Published: (2021)